Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Report Results
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

Controversial Health Topics - Abortion, Obesity, Rx Drug Advertising - Get Fresh Pro and Con Analysis at ProCon.org

ProCon.org logo. (PRNewsFoto/ProCon.org) (PRNewsFoto/)

News provided by

ProCon.org

Jun 10, 2014, 01:20 ET

Share this article

Share toX

Share this article

Share toX

SANTA MONICA, Calif., June 10, 2014 /PRNewswire-USNewswire/ -- America's largest provider of free pro and con research on controversial issues, ProCon.org (online at www.procon.org), has expanded and updated its information on the controversial health topics of abortion, obesity, and prescription drug advertising to consumers.

These three health topics explore the core questions: "Should abortion be legal?," "Is obesity a disease?," and "Should prescription drugs be advertised directly to consumers?"

ProCon.org President and Managing Editor, Kamy Akhavan, commented: "For educators, students, journalists, and the rest of us who want to better understand important social issues without all the bias, inaccuracy, and spin that is too often part of the media, ProCon.org provides free nonpartisan research on 50 controversial issues to help us all make more informed decisions."

Should abortion be legal?
(http://abortion.procon.org)

ProCon.org researchers have presented an extensive background, 30 pro and con arguments (citing 150+ sources), and 31 quotes from authoritative sources including the United Church of Christ (pro), the Republican Party (con), the Democratic Party (pro), and the National Association of Evangelicals (con). The project also features views on abortion from the 10 largest Christian denominations and five largest non-Christian religious groups.

Did You Know?

* From Roe v. Wade in 1973 through 2011, nearly 53 million legal abortions were performed in the United States – an average of about 1.4 million abortions per year. At 2008 abortion rates, three in ten US women will have an abortion before age 45.

* Although the Catholic and Lutheran churches oppose abortion, more of their members believe abortion should be legal in all or most cases versus illegal in all or most cases (51% vs. 45%, Lutheran; 48% vs. 45%, Catholic).

* A woman's risk of dying from having an abortion is 0.6 in 100,000, while the risk of dying from giving birth is around 14 times higher (8.8 in 100,000). The mortality rate of a colonoscopy is more than 40 times greater than that of an abortion.

* 8.5% of abortions reported to the Centers for Disease Control and Prevention in 2010 were undergone by women who had three or more previous abortions.

* More US state abortion restrictions were enacted between 2011 and 2013 (205 in total) than were adopted during the whole previous decade (189).

Is obesity a disease?
(http://obesity.procon.org)

Like all ProCon.org websites, this one includes a background and "did you know?" facts. The obesity website also features 11 pro and con arguments (citing 90+ sources), and 22 quotes from sources including the American Medical Association (pro), David Katz, Editor-in-Chief of Childhood Obesity (con), World Health Organization (pro), and Dr. Andrew Weil (con). The project also includes a visualization of CDC-recommended portion sizes, a global comparison of obesity levels, and a listing of 15 noteworthy anti-obesity drugs.

Did You Know?

* In 2013 the United States was the second most obese industrialized nation with 31.8% of Americans falling into the obese category. Mexico was first at 32.8%.

* In Nov. 2013, the US Surgeon General reported an estimated 300,000 deaths per year may be attributed to obesity. Obesity was the third leading cause of death in 2009, after high blood pressure and smoking.

* Men burned 142 fewer calories daily and weighed 32.8 pounds more in 2003-2006 than in 1960-1962, while women burned 124 fewer calories daily and weighed 25.13 pounds more in 2003-2006 than in 1960-1962.

* Obesity and obesity-related health conditions cost an estimated 10% of annual medical spending in the United States, totaling $147 billion in 2008.

* In 1994 all US states had obesity rates at 19% or lower. By 2010, no state reported an obesity rate under 19%. By 2013, 11 states had obesity rates over 30%.

Should prescription drugs be advertised directly to consumers?
(http://prescriptiondrugs.procon.org)

ProCon.org presents 15 pro and con arguments and 27 quotes from experts including the Pharmaceutical Research and Manufacturers of America (pro), the American College of Physicians (con), the American Advertising Federation (pro), and the World Health Organization (con). The prescription drug ads website also contains a gallery of drug ads from the 1800s to the present, a description of 35 prescription drugs pulled from the market, and a chart showing the number of articles written about prescription drug advertising to consumers from 1983 (one) to 2005 (45) to 2013 (24).

Did You Know?

* Bayer Pharmaceuticals sold heroin as an over-the-counter remedy for coughs in the early 1900s.

* The US Food and Drug Administration did not begin to regulate prescription drug advertisements until Oct. 10, 1962 with the passage of the Kefauver Harris Amendments.

* Every $1.00 spent advertising prescription drugs is estimated to increase their retail sales by $4.20.

* The United States and New Zealand are the only two countries where direct-to-consumer (DTC) advertising of prescription drugs is legal.

* As of May 2011, the average number of prescriptions for new drugs with DTC advertising is nine times greater than prescriptions for new drugs without DTC ads.

About Us
ProCon.org (online at www.procon.org) is a 501(c)(3) nonprofit public charity whose mission is promoting critical thinking, education, and informed citizenship.  Information is presented on 50 different ProCon.org issue websites in subjects ranging from Obamacare, alternative energy, and medical marijuana to the death penalty, illegal immigration, and gay marriage.

ProCon.org websites are free of charge and require no registration.  The websites have been cited dozens of times by the governments of 17 countries (including the United States where 28 states and nine federal agencies reference ProCon.org).

ProCon.org had over 16.6 million unique readers in 2013 and more than 2.9 billion hits since its inception in 2004.

ProCon.org has been referenced by mainstream media 344 times in 2013 (over 1,250 times total), including: 60 Minutes, ABC, Associated Press, Atlanta Journal-Constitution, BBC, Bloomberg, Business Week, CBS News, CNN, CNBC, The Economist, Esquire, Forbes, FOX News, The Guardian, Houston Chronicle, Huffington Post, Los Angeles Times, Mother Jones, NBC, New England Journal of Medicine, New York Times, PBS, Reuters, Slate, USA Today, Washington Post, Wired, and many others.

For information about ProCon.org, visit www.procon.org

Facebook: www.facebook.com/procon.org

Twitter: www.twitter.com/procon_org

Pinterest: www.pinterest.com/proconorg

YouTube: www.youtube.com/proconorg

Tumblr: proconorg.tumblr.com

Logo - http://photos.prnewswire.com/prnh/20130208/MM57290LOGO

CONTACT: Kambiz Akhavan, 310-587-1407, [email protected]

SOURCE ProCon.org

21%

more press release views with 
Request a Demo

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2026 Cision US Inc.